CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 119 filers reported holding CYTOMX THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,763,000 | +205.0% | 212,183 | +171.0% | 0.05% | +250.0% |
| Q3 2019 | $578,000 | -68.5% | 78,283 | -2.6% | 0.01% | -60.0% |
| Q2 2018 | $1,837,000 | -16.5% | 80,339 | +3.9% | 0.04% | -23.9% |
| Q1 2018 | $2,199,000 | -43.3% | 77,298 | -56.0% | 0.05% | -45.2% |
| Q4 2017 | $3,877,000 | +29.2% | 175,733 | +5.8% | 0.08% | +44.8% |
| Q3 2017 | $3,001,000 | +512.4% | 166,079 | +425.6% | 0.06% | +480.0% |
| Q2 2017 | $490,000 | -10.4% | 31,595 | -0.2% | 0.01% | -23.1% |
| Q1 2017 | $547,000 | +101.8% | 31,665 | +28.4% | 0.01% | +30.0% |
| Q4 2016 | $271,000 | – | 24,670 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 5,576,471 | $36,526,000 | 1.44% |
| Altium Capital Management LP | 273,703 | $1,793,000 | 0.67% |
| Jackson Creek Investment Advisors LLC | 80,367 | $526,000 | 0.21% |
| HARBOURVEST PARTNERS LLC | 79,193 | $519,000 | 0.20% |
| XTX MARKETS LLC | 14,169 | $93,000 | 0.19% |
| Perceptive Advisors | 2,577,043 | $16,880,000 | 0.18% |
| RTW INVESTMENTS, LP | 1,527,352 | $10,004,000 | 0.17% |
| Exane Asset Management | 30,568 | $200,220,000 | 0.14% |
| Virtus ETF Advisers LLC | 37,343 | $245,000 | 0.10% |
| Congress Park Capital LLC | 25,807 | $169,000 | 0.10% |